MRNA vs SBUX · rev $145.0M vs P/E 76, rev $37.18B
Moderna Inc (MRNA) versus Starbucks Corporation (SBUX) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Starbucks Corporation (SBUX) is a restaurants company listed on NASDAQ. It is led by Brian R. Niccol.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported SBUX revenue for 2025-09-28 was $37.18B. Net income was $1.86B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
MRNA currently screens at market cap $24.52B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
Not investment advice. Open the MRNA and SBUX stock pages for the full models.
Not investment advice.